DB44/T 2847-2026
DB44 · 2026-05-09
Technical Specification for Prescription Review of Chinese Patent Medicines
1Key Takeaways
This document applies to paper-based prescriptions and electronic prescriptions for Chinese patent medicines.
2Scope / Description
This document applies to paper-based prescriptions and electronic prescriptions for Chinese patent medicines.
3Version History
DB44/T 2847-2026
2026-05-09
5Citation Network
0
Cite this standard
0
Referenced herein
6Frequently Asked Questions
What is DB44/T 2847-2026?
DB44/T 2847-2026 — Technical Specification for Prescription Review of Chinese Patent Medicines is an international standard developed by Guangdong Provincial Standard of the People's Republic of China. This document applies to paper-based prescriptions and electronic prescriptions for Chinese patent medicines.
What does DB44/T 2847-2026 cover?
This standard covers: This document applies to paper-based prescriptions and electronic prescriptions for Chinese patent medicines.
Who should use this standard?
This standard is intended for organizations, professionals, and stakeholders involved in the medical device and healthcare industry. It is applicable to manufacturers, service providers, regulatory bodies, and certification organizations.
What is the latest version of DB44/T 2847-2026?
The current published version is DB44/T 2847-2026, published on 2026-05-09. Always check for amendments or pending revisions.
How do I purchase DB44/T 2847-2026?
You can purchase DB44/T 2847-2026 by visiting our contact page. Click "Get This Standard" to view pricing and send a purchase inquiry. Our team will respond with payment and delivery details.